Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$13.27

-0.3 (-2.21%)

08:08
10/17/16
10/17
08:08
10/17/16
08:08

PTC Therapeutics denied appeal for Translarna by FDA

PTC Therapeutics announced that at the end of last week, the Office of Drug Evaluation I, or ODE-I, of the FDA, denied the company's first appeal of the refuse to file letter issued by the FDA's Division of Neurological Products, or DNP, on February 22 regarding PTC's New Drug Application, or NDA, for Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy, nmDMD. The company intends to escalate its appeal to the next supervisory level of the FDA. This is an iterative process and the company anticipates that multiple cycles of appeals to progressively higher levels of the FDA may be required.

  • 06

    Nov

PTCT PTC Therapeutics
$13.27

-0.3 (-2.21%)

07/20/16
WEDB
07/20/16
NO CHANGE
Target $12
WEDB
Neutral
Wedbush staying on sidelines on PTC Therapeutics after NICE issues guidance
Noting that NICE has finalized access for England for PTC Therapeutics' Translarna, Wedbush analyst Heather Behanna said she remains on the sidelines on PTC shares, citing the drug's continued regulatory and pricing risks in Europe. While keeping a Neutral rating and $12 price target on PTC shares, Behanna said she believes it is unlikely that the EMA will pull the drug from the market and sees "meaningful upside" in early 2017 if Translarna can demonstrate a statistically significant positive result in cystic fibrosis.
07/26/16
FBCO
07/26/16
DOWNGRADE
Target $6
FBCO
Neutral
PTC Therapeutics downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Alethia Young downgraded PTC Therapeutics to Neutral and lowered its price target to $6 from $12 citing further uncertainty around the Eurozone DMD approval case. Following the company's release, Young believes that the approval timelines in EU at the best case are now longer than his original expectations though the drug does remain on the market and lowered his probability of success in EMA to 75% from $100.
09/20/16
JEFF
09/20/16
NO CHANGE
Target $7
JEFF
Hold
Jefferies thinks eteplirsen approval will have limited impact on PTC
Jefferies analyst Gena Wang believes yesterday's FDA approval of Sarepta Therapeutics' (SRPT) eteplirsen will have a limited impact on PTC Therapeutics (PTCT). While PTC's potential treatment for Duchenne muscular dystrophy ataluren is considered safe, the FDA approval of eteplirsen is mainly based on the marginal increase of dystrophin level and PTC does not have any dystrophin data from Phase 3, Wang tells investors in a research note. Eteplirsen's approval could pressure the FDA to reconsider the review progress of ataluren, but the final outcome would likely remain the same, the analyst contends. She keeps a Hold rating on PTC with a $7 price target. The stock closed yesterday up 21%, or $1.88, to $10.99.
10/03/16
BOFA
10/03/16
NO CHANGE
Target $15
BOFA
Buy
PTC Therapeutics price target raised to $15 from $9 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised PTC Therapeutics' price target to $15 from $9 following partner Roche's recruitment for a trial it is conducting to investigate a potential treatment for Spinal Muscular Atrophy, or SMA, patients. Given this advancement, the analyst is raising his probability of approval to 30% from 20% in SMA and maintains his Neutral rating.

TODAY'S FREE FLY STORIES

CSGP

CoStar Group

$210.02

-1.35 (-0.64%)

17:24
02/22/17
02/22
17:24
02/22/17
17:24
Earnings
Breaking Earnings news story on CoStar Group »

CoStar Group sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

CSGP

CoStar Group

$210.02

-1.35 (-0.64%)

17:24
02/22/17
02/22
17:24
02/22/17
17:24
Hot Stocks
Breaking Hot Stocks news story on CoStar Group »

CoStar Group sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

CSGP

CoStar Group

$210.02

-1.35 (-0.64%)

17:22
02/22/17
02/22
17:22
02/22/17
17:22
Earnings
Breaking Earnings news story on CoStar Group »

CoStar Group sees Q1 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

IAG

IAMGold

$4.41

-0.05 (-1.12%)

17:20
02/22/17
02/22
17:20
02/22/17
17:20
Hot Stocks
Breaking Hot Stocks news story on IAMGold »

IAMGold sees 2017 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAG

IAMGold

$4.41

-0.05 (-1.12%)

17:19
02/22/17
02/22
17:19
02/22/17
17:19
Hot Stocks
Breaking Hot Stocks news story on IAMGold »

IAMGold sees 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAG

IAMGold

$4.41

-0.05 (-1.12%)

17:17
02/22/17
02/22
17:17
02/22/17
17:17
Earnings
IAMGold reports Q4 EPS 0c, consensus 0c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGG

Graco

$91.94

-0.18 (-0.20%)

17:17
02/22/17
02/22
17:17
02/22/17
17:17
Hot Stocks
Graco rebrands, redesigns Airlessco airless sprayer line »

Graco launched a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

DDC

Dominion Diamond

$9.21

-0.27 (-2.85%)

17:16
02/22/17
02/22
17:16
02/22/17
17:16
Hot Stocks
Dominion Diamond sees FY18 production 6.3M-7M carats »

During fiscal 2018, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$13.66

-0.68 (-4.74%)

17:15
02/22/17
02/22
17:15
02/22/17
17:15
Hot Stocks
Oasis Petroleum projects FY17 CapEx $605M »

Sees Fy17 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 05

    Mar

OAS

Oasis Petroleum

$13.66

-0.68 (-4.74%)

17:14
02/22/17
02/22
17:14
02/22/17
17:14
Hot Stocks
Oasis Petroleum reports Q4 non-GAAP EPS (8c), consensus (12c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 05

    Mar

DDC

Dominion Diamond

$9.21

-0.27 (-2.85%)

17:13
02/22/17
02/22
17:13
02/22/17
17:13
Hot Stocks
Dominion Diamond reports Q4 diamond sales $129.9M »

During the fourth fiscal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$16.20

0.07 (0.43%)

17:13
02/22/17
02/22
17:13
02/22/17
17:13
Earnings
HP Inc. sees FY17 adjusted EPS $1.55-$1.65, consensus $1.59 »

Sees FY17 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 17

    Apr

CAKE

Cheesecake Factory

$60.10

-0.57 (-0.94%)

17:12
02/22/17
02/22
17:12
02/22/17
17:12
Earnings
Cheesecake Factory sees FY17 adjusted EPS $2.95-$3.07, consensus $3.05 »

Backs FY17 SSS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 08

    Mar

CAKE

Cheesecake Factory

$60.10

-0.57 (-0.94%)

17:11
02/22/17
02/22
17:11
02/22/17
17:11
Earnings
Cheesecake Factory sees Q1 adjusted EPS 71c-74c, consensus 73c »

Sees Q1 SSS growth flat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 08

    Mar

IOC

InterOil

$48.36

-0.04 (-0.08%)

, XOM

Exxon Mobil

$80.93

-0.96 (-1.17%)

17:11
02/22/17
02/22
17:11
02/22/17
17:11
Hot Stocks
Exxon Mobil completes acquisition of InterOil »

InterOil (IOC) completed…

IOC

InterOil

$48.36

-0.04 (-0.08%)

XOM

Exxon Mobil

$80.93

-0.96 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGR

Sturm, Ruger

$50.30

1 (2.03%)

17:09
02/22/17
02/22
17:09
02/22/17
17:09
Hot Stocks
Breaking Hot Stocks news story on Sturm, Ruger »

Sturm Ruger declares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

RGR

Sturm, Ruger

$50.30

1 (2.03%)

17:08
02/22/17
02/22
17:08
02/22/17
17:08
Earnings
Sturm Ruger reports Q4 EPS $1.10 vs. 88c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

ALB

Albemarle

$92.44

-1.34 (-1.43%)

17:07
02/22/17
02/22
17:07
02/22/17
17:07
Hot Stocks
Albemarle and Tianqi terminate option for interest acquisition »

Albemarle and Tianqi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 16

    Mar

LTC

LTC Properties

$47.13

0.24 (0.51%)

17:07
02/22/17
02/22
17:07
02/22/17
17:07
Earnings
LTC Properties reports Q4 FFO 78c vs. 74c last year »

Reports Q4 diluted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 01

    Mar

ERN

Erin Energy

$3.55

-0.1 (-2.74%)

17:05
02/22/17
02/22
17:05
02/22/17
17:05
Hot Stocks
Erin Energy CEO Segun Omidele resigns »

Erin Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip.com

$47.59

0.53 (1.13%)

17:04
02/22/17
02/22
17:04
02/22/17
17:04
Earnings
Ctrip.com reports Q4 non-GAAP EPS 32c, may not compare to consensus (3c) »

Reports Q4 revenue $730M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

OSIS

OSI Systems

$77.18

-0.51 (-0.66%)

17:04
02/22/17
02/22
17:04
02/22/17
17:04
Hot Stocks
OSI Systems sells German Healthcare unit for roughly EUR11.7M »

OSI Systems announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLX

TPG Specialty Lending

$19.41

-0.02 (-0.10%)

17:03
02/22/17
02/22
17:03
02/22/17
17:03
Hot Stocks
TPG Specialty Lending extends stock repurchase plan »

TPG Specialty Lending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

RMAX

RE/MAX Holdings

$60.45

0.05 (0.08%)

17:02
02/22/17
02/22
17:02
02/22/17
17:02
Hot Stocks
RE/MAX Holdings raises quarterly dividend 20% to 18c per share »

The quarterly dividend is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 09

    Mar

TSLX

TPG Specialty Lending

$19.41

-0.02 (-0.10%)

17:02
02/22/17
02/22
17:02
02/22/17
17:02
Earnings
TPG Specialty Lending reports Q4 NII 47c, consensus 44c »

Reports net asset value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.